TARGESON, LLC

Company Information

Company Name
TARGESON, LLC
Address
850 CARLINS WAY
CHARLOTTESVILLE, VA, 22903-7666
Phone
n/a
URL
n/a
DUNS
610945474
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$843,709.00
6
SBIR Phase II
$1,030,154.00
1
Chart code to be here

Award List

  1. Novel Microparticle Contrast Agent for Near Infrared Molecular Imaging

    Amount: $177,726.00

    DESCRIPTION (provided by applicant): Molecular imaging techniques have demonstrated efficacy in the setting of preclinical research, primarily for drug discovery and basic science. Optical imaging has ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Gene Delivery Agents for Ultrasound-Mediated Transfection

    Amount: $99,867.00

    DESCRIPTION (provided by applicant): We propose to develop a novel acoustically activated microbubble gene delivery vehicle for treatment of experimental inflammatory bowel disease. Microbubble ultras ...

    SBIR Phase I 2007 Department of Health and Human Services
  3. Multi-Targeted Contrast Ultrasound Agent for Imaging Angiogenesis

    Amount: $104,679.00

    DESCRIPTION (provided by applicant): Targeson has developed and commercialized a microbubble contrast agent that is suitable for conjugation to an array of molecular targeting ligands via an avidin/bi ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Ultrasound Contrast Agents for Inflammation and Angiogenesis

    Amount: $99,729.00

    DESCRIPTION (provided by applicant): We propose to develop molecular imaging probes for imaging angiogenesis and inflammation using contrast-enhanced ultrasound. These probes are gas-encapsulated micr ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Ultrasound mediated targeted therapy for kidney disease

    Amount: $166,046.00

    DESCRIPTION (provided by applicant): Antibodies can be used diagnostically as ligands for molecular imaging, and also as therapeutic to neutralize factors involved in the development of kidney disease ...

    SBIR Phase I 2009 Department of Health and Human Services
  6. Ultrasound Contrast Agents for Inflammation and Angiogenesis

    Amount: $1,030,154.00

    DESCRIPTION (provided by applicant): Site-targeted microbubbles (MB) have demonstrated potential as a molecular imaging tool. A new targeted MB platform was developed in phase I of this project. This ...

    SBIR Phase II 2009 Department of Health and Human Services
  7. Contrast agents for high-sensitivity ultrasound molecular imaging of tumor angiog

    Amount: $195,662.00

    DESCRIPTION (provided by applicant): Molecular imaging techniques have strong potential in the setting of preclinical research, primarily for drug discovery and basic science in the field of cancer re ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government